Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

The EFSUMB created basic guidelines for using ultrasound in skin-related medical practice.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Reflectance confocal microscopy is a useful, non-invasive tool for diagnosing some skin diseases, with potential for future improvements.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The document concludes that recent studies help tell apart desmoplastic trichoepitheliomas from other skin tumors, but more research is needed for clear differentiation.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The document explains various skin conditions and their treatments.

Genetic mutations can affect female sexual development, requiring personalized medical care.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

FFA has higher long-term remission rates than LPP.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.